3041B |
Metoclopramide, Blood |
3041SP |
Metoclopramide, Serum/Plasma |
3041U |
Metoclopramide, Urine |
3216B |
Nordiazepam and Metabolite, Blood |
3216SP |
Nordiazepam and Metabolite, Serum/Plasma |
3216U |
Nordiazepam and Metabolite, Urine |
3232B |
Omeprazole / Esomeprazole, Blood |
3232SP |
Omeprazole / Esomeprazole, Serum/Plasma |
3260B |
Oxazepam, Blood |
3260SP |
Oxazepam, Serum/Plasma |
3260U |
Oxazepam, Urine |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3560B |
Pheniramine, Blood |
3740B |
Phenyltoloxamine, Blood |
3740SP |
Phenyltoloxamine, Serum/Plasma |
3970B |
Promethazine, Blood |
3970SP |
Promethazine, Serum/Plasma |
3970TI |
Promethazine, Tissue |
3970U |
Promethazine, Urine |